No febrile neutropenia occurred and 25 (21.9% of the entire population) patients received G-CSF; among these, 11 (12.5%) patients developed grade < 3 neutropenia whereas 14 (53.8%) patients developed grade ≥ 3 (p = 0.01). This evidence concerns the gene CSF3 and Decreased total neutrophil count.